Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03321227
Other study ID # Ryerson-REB-2017
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 9, 2018
Est. completion date December 1, 2019

Study information

Verified date March 2020
Source Ryerson University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the present study is to determine the effects of eggs and egg components on cognitive performance and appetite in children aged 9-14 years, as well as to identify the underlying physiological mechanisms in this relationship.


Description:

Children will be asked to refrain from exercising the morning of their test day and inform researchers of any illness. Following a 12-hour overnight fast, children will consume a standardized breakfast of a cereal bar, fruit cup and orange juice at home (total 330 kcal). Children will be asked to avoid consumption of any other food, with the exception of water, until arrival at the laboratory 3 hours later.

At the laboratory, five treatments of: (a) 2 whole eggs, (b) 2 egg whites, (c) 2 egg yolks, (d) full fat yogurt isocaloric to the 2 whole eggs, and (e) snack skipping will be provided to children 9-14 years on separate days at least 7 days apart. Cognitive performance, subjective emotion/mood, and subjective appetite will be measured for 90-minutes following snack consumption (n=25). Cognitive performance assessments will include learning and memory, spatial memory, attention and processing speed, and executive functions. In a subgroup of individuals (n=10), glucose, insulin, incretin hormones (glucagon like peptide1(GLP1) and gastric inhibitory polypeptide (GIP)),dipeptidyl peptidase 4 (DPP4), amino acids, fatty acids, and choline will be measured for 90-minutes following snack consumption.


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date December 1, 2019
Est. primary completion date December 1, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 9 Years to 14 Years
Eligibility Inclusion Criteria:

- be between 9 and 14 years of age

- be healthy, and have been born at term

- healthy body weight (between the 5th and 85th BMI percentile for age and gender)

Exclusion Criteria:

- children with food sensitivities or allergies to eggs, egg-products, dairy and wheat

- children with any diagnosed learning, emotional, or behavioral disabilities

- children on medications that may influence cognitive performance

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Snack skipping
No snack provided
Whole eggs
2 whole large eggs scrambled, provided as a snack
Egg whites
2 egg whites scrambled, provided as a snack
Egg yolks
2 egg yolks scrambled, provided as a snack
Yogurt
A serving of full fat yogurt that is isocaloric to the 2 whole eggs

Locations

Country Name City State
Canada School of Nutrition, Ryerson University Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
Ryerson University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in memory from baseline One of five word lists composed of 15 words will be audio-visually presented to children. The majority of the words will be one syllable, and four words in each list will be two syllables long. The list will be presented at baseline and the children will be asked to recall as many words as possible at each time-point. The list will be presented for 2.5 minutes, and children will have 2 minutes for both immediate and delayed recall. 15, 30, 60, and 90 minutes
Primary Change in spatial working memory from baseline Assessed using a spatial pattern recognition test via the Membrain application. The test consists of a series of subtests where children will be presented a picture with patterns to study, and asked to identify a picture with the same pattern from a group of four images. This test will be at each time-point and takes approximately 1 minute to complete. 0, 15, 30, 60, and 90 minutes
Primary Change in attention from baseline The continuous performance task (CPT) will be completed via the Membrain application. During the CPT task, children will be given a sequence of two letters to identify; for example respond to the detection of the letter "X" only when it is preceded by the letter "A". This task will be at each time-point and will take 3 minutes total to complete. 0, 15, 30, 60, and 90 minutes
Primary Change in executive function from baseline The Stroop task will be completed via the Membrain application. Children will be presented with a list of words presented in colors that match the word (congruent, the word 'red' presented in red) or colors that do not match the word (incongruent, the word 'red' presented in blue). Children will be asked to identify the color of the word, not the word itself. The task is scored for the number of correct and incorrect colors identified, as well as total time to completion. This test will be at each time-point and will take 1 minute to complete. 0, 15, 30, 60, and 90 minutes
Secondary Change from baseline mood Measured using visual analogue scale (mm). Each VAS is a 100 mm line where they will place a pencil mark to describe their feelings.These emotions will be seperated into three categories including, subjective emotions (aggressive, angry, excited, disappointed, and frustrated), global vigour and affect (alert, sad, tense, effort, happy, weary, calm and sleepy), and wellness. These sub scales will be combined to compute an average total score for each category. 0, 15, 30, 60, and 90 minutes
Secondary Change from baseline subjective appetite Measured using visual analogue scale (mm). Each VAS is a 100 mm line where they will place a pencil mark to describe their feelings. Average appetite will combine four questions (desire to eat, hunger, fullness, and prospective food consumption) to calculate the score. 0, 15, 30, 60, and 90 minutes
Secondary Change from baseline cholecystokinin (CCK) Blood CCK (pmol/L). CCK concentration in serum will be determined in duplicate via enzymelinked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts). 0, 15, 30, 60, and 90 minutes
Secondary Change from baseline dipeptidyl peptidase 4 (DPP4) Blood DPP4 (ng/mL). DPP4 concentration in serum will be determined in duplicate via enzymelinked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts). 0, 15, 30, 60, and 90 minutes
Secondary Change from baseline glucagonlike peptide1 (GLP1) Blood GLP1 (pmol/L). GLP1 concentration in serum will be determined in duplicate via enzymelinked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts). 0, 15, 30, 60, and 90 minutes
Secondary Change from baseline insulin Blood insulin (pmol/L). Insulin concentration in serum will be determined in duplicate via enzymelinked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts). 0, 15, 30, 60, and 90 minutes
Secondary Change from baseline glycemic response Blood glucose will be measured in whole blood using YSI 2300 STAT PLUS (YSI Incorporated, Yellow Springs, OH) 0, 15, 30, 60, and 90 minutes
Secondary Change from baseline amino acids From plasma blood samples. Amino acids will be determined using the pre-column derivatization HPLC procedure. A plasma sample will be de-proteinizied with a 5-sulfosalicyclic acid solution, then centrifuged at 4°C and 18,400 G for 15 minutes. The amino acids will be derivatized from the sample with ortho-phthaldehyde reagent. The sample will then be analyzed using the Perkin Elmer Series HPLC System in the Ryerson University Analytical Centre. 0, 15, 30, 60, and 90 minutes
Secondary Change from baseline fatty acids From plasma blood samples. Fatty acids will be assessed via gas chromatography, an effective method to measure both the proportions and concentrations of fatty acids in plasma. A plasma sample will be prepared by trans-esterification of total lipid aliquots with a MeOH/HCl mixture and n-hexane. The sample will then be analyzed using the Perkin Elmer Auto-System in the Ryerson University Analytical Centre. 0, 15, 30, 60, and 90 minutes
Secondary Change from baseline choline From plasma blood samples. Will be analyzed for choline using a fluorimetric assay; free choline will be oxidized by choline oxidase to betaine and H2O2 that reacts with a specific dye to form a pink colored product. The fluorescence intensity at 530/585 nm is directly proportional to the choline concentration in the sample. 0, 15, 30, 60, and 90 minutes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Completed NCT02376530 - Price Changes and Nutrient Profiling Among Adult Grocery Shoppers N/A
Completed NCT01040975 - Teen CHAT: Improving Physician Communication With Adolescents About Healthy Weight N/A
Completed NCT00957814 - Nutritional Orientations and Adherence, Nutritional Status, Clinical and Life Quality Parameters of Heart Failure (HF) Patients N/A
Completed NCT00808756 - Study on Fermentable Carbohydrates in Healthy Infants N/A
Completed NCT03290118 - The Efficacy of Front-of-package Labelling Schemes: an Experimental Study N/A
Completed NCT03575884 - Fit 5 Kids Screen Time Reduction Curriculum for Latino Preschoolers N/A
Completed NCT03963778 - Organisational Culture and Nutritional Care
Completed NCT05633251 - Using Reinforcement Schedules to Increase Fruit&Vegetable Intake, Reduce Waste, and Increase School Lunch Participation N/A
Recruiting NCT05138276 - Effect of Autologous Cord Blood Mononuclear Cells for Digestive System in Preterm Neonates Early Phase 1
Completed NCT03906851 - Active and Healthy Kids in Telemark - a School Based Health Promoting Intervention N/A
Not yet recruiting NCT02950779 - Assessment of Handgrip Strength in Adults With Inflammatory Bowel Disease N/A
Completed NCT02486588 - Increasing Engagement With a Healthy Food Benefit N/A
Withdrawn NCT01184027 - Impact of Nutrition and Swallowing Function of Head and Neck Cancer Patients During the Course of Treatment N/A
Completed NCT01178398 - Understanding Fish Consumption Habits During Pregnancy N/A
Completed NCT01249508 - Nutrition Labeling Program to Promote Healthy Dietary Patterns N/A
Terminated NCT00577499 - Effect of Lubiprostone on Nutritional Status and Pulmonary Function in Adults With Cystic Fibrosis N/A
Completed NCT00109551 - Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern Nepal Phase 3
Completed NCT03910426 - Prognostic Determinants of Survival and Quality of Life in Prevalent End-stage Kidney Disease Patients
Recruiting NCT04146870 - Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation